Federal Court Reconsiders Cannabis’ Classification as a Schedule 1 Drug
As of May 30, news opinions are pressuring the DEA into conducting an administrative review as plaintiffs continue to insist on the life-altering health threats that the current scheduling of cannabis ensues.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed